Business Context and Reporting Period
Company: Kimberly-Clark Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2005
Business Overview: The Corporation operates three global segments: Personal Care (diapers, feminine care), Consumer Tissue (facial/bathroom tissue), and Business-to-Business (health and hygiene products). Following the November 30, 2004 spin-off of Neenah Paper, Inc., the fine paper and technical paper businesses are reported as discontinued operations.
Key Financial Metrics
| Metric (Millions, except per share) | Q1 2005 | Q1 2004 |
|---|---|---|
| Net Sales | $3,905.8 | $3,711.5 |
| Gross Profit | $1,306.6 | $1,255.7 |
| Operating Profit | $637.6 | $623.4 |
| Net Income | $450.1 | $459.3 |
| Diluted EPS (Continuing Ops) | $0.93 | $0.88 |
| Cash Provided by Operations | $608.4 | $605.0 |
| Cash and Cash Equivalents (End of Period) | $833.5 | $329.0 |
| Total Debt (Short + Long Term) | $3,714.3 | Not directly comparable due to balance sheet date |
Note: Total Debt calculated as Debt payable within one year ($1,435.6M) + Long-Term Debt ($2,278.7M) as of March 31, 2005.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 5.2% year-over-year, driven by a 3% favorable currency impact, 2% higher sales volumes, and a 1% improvement in net selling prices.
- Profitability: Operating profit rose 2.3% despite significant cost inflation (approx. $100M), including over $50M in raw material costs (resin and fiber) and $25M in distribution costs. Cost savings of approx. $45M helped offset these increases.
- Segment Performance:
- Personal Care: Sales up 3.6%; Operating profit down 4.5% due to lower net selling prices and raw material inflation.
- Consumer Tissue: Sales up 7.4%; Operating profit flat, as price increases were offset by higher costs.
- Business-to-Business: Sales down 1.5% (impacted by pulp divestiture); Operating profit up 17.9% due to volume growth and absence of prior-year pulp losses.
- Discontinued Operations: Q1 2004 included $15.5M income from discontinued operations (Neenah Paper), whereas Q1 2005 had none.
- Share Count: Average shares outstanding declined due to the share repurchase program, contributing $0.04 to EPS growth.
Guidance, Outlook, and Risks
- 2005 Full-Year Guidance:
- Sales Growth: Targeting 3% to 5% growth.
- Operating Profit: Targeting 3% to 6% growth.
- Earnings Per Share: Expecting $3.70 to $3.85 (mid- to high single-digit growth vs. 2004).
- Q2 2005 Outlook: Earnings anticipated in the range of $0.92 to $0.94 per share.
- Capital Allocation: Maintaining a target of $1 billion or more for share repurchases in 2005; capital spending target remains $800 million for the full year.
- Risks and Contingencies:
- Cost Inflation: Continued escalation in raw material (resin, fiber) and energy costs.
- Currency: Weakness in the euro, British pound, Swiss franc, and Australian dollar negatively impacted comprehensive income ($145.3M unrealized loss).
- Competitive Pressure: Intense competition in North America and Europe, particularly in diapers and training pants.
- Accounting Changes: Evaluating adoption of SFAS 123R (Share-Based Payment) effective Jan 1, 2006, and FIN 47 (Asset Retirement Obligations) effective Dec 31, 2005.
Investor Verification Checklist
- Cost Inflation Impact: Verify the sustainability of cost savings initiatives against rising resin and fiber prices.
- Currency Exposure: Assess the impact of a strengthening U.S. dollar on future earnings, given the significant unrealized translation losses in Q1.
- Share Repurchase Execution: Confirm the pace of the $1 billion+ repurchase program against cash flow generation.
- Segment Mix: Monitor the shift in profitability between Personal Care (margin pressure) and Business-to-Business (margin expansion).
- Discontinued Operations: Ensure comparisons exclude the Neenah Paper spin-off effects present in 2004 data.